Daniel L Hertz, PharmD, PhD
Advertisement
Articles by Daniel L Hertz, PharmD, PhD
Advertisement
Latest Updated Articles
DPYD Testing Gains Ground: NCCN Guideline Update Reflects Decades of Work Toward Safer ChemotherapyPublished: April 25th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted Therapy
2
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
3
FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms
4
New Data Show Elinzanetant Is a Safe, Well-Tolerated Non-Hormonal Therapy for Menopausal Vasomotor Symptoms
5
